Hypophosphatemia With Ferric Carboxymaltose Vs. Iron Dextran in Iron Deficiency Secondary to Heavy Uterine Bleeding

NCT01307007 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

69

Enrollment

INDUSTRY

Sponsor class

Conditions

Iron Deficiency Anemia

Interventions

DRUG: Ferric Carboxymaltose (FCM)
DRUG: Iron Dextran Injection

Sponsor

American Regent, Inc.